Metabolism of the chloroethylnitrosoureas

References

• Cheng C. J., Fujimura S., Granberger D., Weinstein I. B. Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteins in vivo and in vitro. Cancer Research 1972; 32: 22–27
   Google Scholar
• Chirigos M. A., Humphrey S. R., Goldin A. Duration of effective levels of three antitumour drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Cancer Chemotherapy Reports 1965; 49: 15–19
   Google Scholar
• Clapper M. L., Buller A. L., Smith T. M., Tew K. D. Glutathione S-transferases in alkylating agent resistant cells. Glutathione S-transferases and Carcinogenesis, T. J. Mantle, C. B. Pickett, J. D. Haynes. Taylor & Francis, London 1987; 213–224
   Google Scholar
• Colvin M., Cowens J. W., Brundrett R. B., Kramer B. S., Ludlum D. B. Decomposition of BCNU (1,3-Bis(2-chloroethyl)-l-nitrosourea) in aqueous solution. Biochemical and Biophysical Research Communication 1974; 60: 515–520
   Google Scholar
• Colvin M., Brundrett B., Cowens W., Jardine I., Ludlum B. A chemical basis for the antitumor activity of chloroethylnitrosoureas. Biochemical Pharmacology 1976; 25: 695–699
   PubMed Web of Science ®Google Scholar
• Day R. S., Ziolkowski C. H. J., Scudiero D. A., Meyer S. T., Mattem M. Human tumor cell strains defective in repair of alkylation damage. Carcinogenesis 1980a; 1: 21–32
   PubMed Web of Science ®Google Scholar
• Day R. S., Ziolkowski C. H. J., Scudiero D. A., Galloway S. M., Bynum G. D. Defective repair of alkylated DNA by human tumor and SV40-transformed human cell strains. Nature 1980b; 288: 724–727
   PubMed Web of Science ®Google Scholar
• Erickson L. C., Bradley M. O., Ducore J. M., Ewig R. A. G., Kohn K. W. DNA crosslinking and cytoxicity in normal and transformed human cells treated with antitumor nitrosoureas. Proceedings of National Academy of Sciences, USA 1980a; 77: 467–471
   Google Scholar
• Erickson L. C., Laurent G., Sharkey N. A., Kohn K. W. DNA crosslinking and monoadduct repair in nitrosourea-treated human tumor cells. Nature 1980b; 288: 727–729
   PubMed Web of Science ®Google Scholar
• Fornace A. J., Kohn K. W., Kann H. E. Inhibition of the ligase step of excision repair by l-Chloroethyl isocyanate, a decomposition product of 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Research 1978; 38: 1064–1069
   Google Scholar
• Gibson N. W., Mattes W. B., Hartley J. A. Identification of specific DNA lesions induced by three classes of chloroethylating agents: chloroethylnitrosoureas, chloroethylmethanesulfonates and chloroethylimidazotetrazines. Pharmacology and Therapeutics 1985; 31: 153–163
   Google Scholar
• Gibson N. W., Hartley J. A., Strong J. M., Kohn K. W. 2-Chloroethyl(methylsulfonyl)-methanesulfonate (NSC-338947), a more selective DNA alkylating agent than chloroethylnitrosoureas. Cancer Research 1986; 46: 553–557
   Google Scholar
• Godeneche D., Moreau M. F., Madelmont J. C., Duprat J., Plagne R. Disposition and metabolism of 1-(2-chloroethyl-3-(2′,3′,4′,tri-O-acetyl ribopyranosyl)-1-nitrosourea in rats. Cancer Research 1982; 42: 525–529
   PubMed Web of Science ®Google Scholar
• Godeneche D., Madelmont J. C., Moreau M. F., Duprat J., Chabard J. L., Plagne R., Meyniel G. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats. Drug Metabolism and Disposition 1985; 13: 220–226
   PubMed Web of Science ®Google Scholar
• Godenéche D., Madelmont J. C., Labarre P., Plagne R., Meyniel G. Disposition of new sulphur-containing 2-(Chloroethyl)nitrosoureas in rats. Xenobiotica 1987; 17: 59–70
   PubMed Web of Science ®Google Scholar
• Gordon B. H., Richards R. P., Hiley M. P., Gray A. J., Ings R. M. J., Campbell D. B. A new method for the measurement of nitrosoureas in plasma: an HPLC procedure for the measurement of fotemustine kinetics. Xenobiotica 1989; 19: 329–339
   PubMed Web of Science ®Google Scholar
• Greene M. O., Greenberg J. The activity of nitrosoguanidine against ascites tumors in mice. Cancer Research 1960; 20: 1166–1171
   Google Scholar
• Hall A., Harris A. L., Hickson I. D., Jacobs E. A., Proctor S. J., Robson C. N. The involvement of glutathione and glutathione S-transferases in cellular resistance to nitrogen mustards. Glutathione S-transferases and Carcinogenesis, T. J. Mantle, C. B. Pickett, J. D. Haynes. Taylor & Francis, London 1987; 245
   Google Scholar
• Hayes J. D., McLellan L. C., Stockman P. K., Chalmers J., Beckett G. J. Glutathione S-transferases in man: the relationship between rat and human enzymes. Biochemical Society Transactions 1987; 15: 721–725
   PubMed Web of Science ®Google Scholar
• Heal J. M., Fox P., Schein P. S. A structure-activity study of seven new water soluble nitrosoureas. Biochemical Pharmacology 1979a; 28: 1301–1306
   Google Scholar
• Heal J. M., Fox P. A., Schein P. S. Effect of carbamoylation on the repair of nitrosourea induced DNA alkylation damage in L1210 cells. Cancer Research 1979b; 39: 82–89
   Google Scholar
• Hill D. L., Kirk M. C., Stuck R. F. Microsomal metabolism of nitrosoureas. Cancer Research 1975; 35: 296–301
   PubMed Web of Science ®Google Scholar
• Ings R. M. J., Gray A. J., Taylor A. R., Gordon B. H., Breen M., Hiley M., Brownsill R., Marchant N., Richards R., Wallace D., Hughes T., Thomas R., Williams J., Lucas C., Campbell D. B. Disposition, pharrnacokinetics and metabolism of 14C-fotemustine in cancer patients. European Journal of Cancer 1990; 26: 838–842
   PubMed Web of Science ®Google Scholar
• Kann H. E., Kohn K. W., Lyles J. M. Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-i-nitrosourea breakdown products 2-chloroethylisocyanate. Cancer Research 1974; 34: 398–402
   Google Scholar
• Khayat I. D., Lokiec F., Bizzari J.-P., Weil M., Meeus L., Sellami M., Rousesse J., Banzet P., Jacquillat C. Phase I clinical study of the new amino acid-linked nitrosourea, S10036, administered as a weekly schedule. Cancer Research 1987; 47: 6782–6785
   PubMed Web of Science ®Google Scholar
• Kline I., Gang M., Tyrer D., Mantel D., Venditti J., Goldin A. Duration of drug levels in mice, as indicated by rat antileukemic efficacy. Chemotherapy 1968; 13: 28–41
   Google Scholar
• Kohn K. W. Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Research 1977; 37: 1450–1454
   PubMed Web of Science ®Google Scholar
• Kramer B. S., Fenselau C. A., Ludlum D. B. Reaction of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea with polycytidylic acid. Substitution of the cytosine ring. Biochemical and Biophysical Research Communications 1974; 56: 783–788
   PubMed Web of Science ®Google Scholar
• Levin V. A., Stearns J., Byrd A., Finn A., Weinkam R. J. The effects of phenobarbital pretreatment on the antitumour activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU) and on the plasma pharmacokinetics and biotransformation of BCNU. Journal of Pharmacology and Experimental Therapeutics 1979; 208: 1–6
   PubMed Web of Science ®Google Scholar
• Lin H.-S., Weinkam R. J. Metabolism of 1,3-bis(2-chloroethyl)-1-nitrosourea by rat hepatic microsomes. Journal of Medicinal Chemistry 1981; 24: 761–763
   Google Scholar
• Lown J. W., Chauhan S. M. Mechanism of action of 2-(haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylamino)-3-nitroso-oxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl),1-(2-chloroethyl)-3-cyclohexyl and 1-(2-chloroethyl)-3–4′-trans-methylcyclohexyl)-1-nitrosourea. Journal of Medicinal Chemistry 1981; 24: 270–279
   Google Scholar
• Lown J. W., McLaughlin L. W., Chang Y. Mechanism of action of 2-haloethyl-nitrosoureas on DNA and its relation to their antileukemic properties. Biorganic Chemistry 1978; 7: 97–110
   Web of Science ®Google Scholar
• Ludlum D. B., Tong W. P. Mechanism of action of the nitrosoureas II. Formation of fluorethyl guanosine from reaction of bis-fluoroethylnitrosourea and guanosine. Biochemical Pharamacology 1978; 27: 2391–2394
   Google Scholar
• Ludlum D. B., Kramer B. S., Wang J., Fenselau C. C. Reaction of 1,3-bis(2-chloroethyl)-1-nitrosourea with synthetic polynucleotides. Biochemistry 1975; 14: 5480–5485
   PubMed Web of Science ®Google Scholar
• Madelmont J. C., Moreau M. F., Godenéche D., Duprat J., Plagne R., Meyniel G. Main metabolites of 1-(2-chloroethyl)-3-[r-(5′-p-nitrobenzoyl-2′,3′-isopropylidene)-α,β-D-ribobofuranosyl]-2-nitrosourea in rats. Drug Metabolism and Disposition 1982; 10: 662–666
   PubMed Web of Science ®Google Scholar
• May H. E., Boose R., Reed D. J. Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes. Biochemical and Biophysical Research Communications 1974; 57: 426–433
   PubMed Web of Science ®Google Scholar
• Mitchell E. P., Schein P. S. Contributions of nitrosoureas to cancer treatment. Cancer Treatment Reports 1986; 70: 31–41
   PubMedGoogle Scholar
• Nishigaki T., Nakamura K., Kinoshita T., Kuwano H., Tanaka M. Identification of major metabolites of [(4 amino 2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) hydrochloride. Journal of Pharmacobiodynamics 1985a; 8: 401–408
   Google Scholar
• Nishigaki T., Nakamura K. I., Tanaka M. In vitro metabolism of ACNU 3-[(4 amino 2- methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride, a water soluble antitumor nitrosourea. Journal of Pharmacobiodynamics 1985b; 8: 409–416
   Google Scholar
• Oliverio V. T. Pharmacology of the nitrosoureas: an overview. Cancer Treatment Reports 1976; 60: 703–707
   PubMedGoogle Scholar
• Oliverio V. T., Vietzke W. A., Williams M. K., Adamson H. The absorption, distribution, excretion and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals. Cancer Research 1970; 30: 1330–1337
   Google Scholar
• Panasci L. C., Fox P. A., Schein P. S. Structure-activity studies of methylnitrosourea antitumor agents with reduced murine bone marrow toxicity. Cancer Research 1977a; 37: 3321–3328
   Google Scholar
• Panasci L. C., Green D., Nagourney R., Fox P., Schein P. S. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice. Cancer Research 1977b; 37: 2615–2618
   PubMed Web of Science ®Google Scholar
• Pinsky S., Tew K. D., Smulsen M. E., Wolley P. V. Modification of L1210 cell nuclear proteins by 1-methyl-1-nitrosourea and 1-methyl-3-nitro-1-nitrosoguanidine. Cancer Research 1979; 39: 923–928
   Google Scholar
• Potter D. W., Reed D. J. Denitrosation of carcinostatic nitrosoureas by purified NADPH cytochrome P450 reductase and rat liver microsomes to yield nitric oxide under anaerobic conditions. Archives of Biochemistry and Biophysics 1982; 216: 158–169
   PubMed Web of Science ®Google Scholar
• Potter D. W., Levin W., Ryan D. E., Thomas P. E., Reed D. J. Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1 nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methyl cyclchexyl)-1-nitrosourea by purified cytochrome P450 isoenzymes. Biochemical Pharmacology 1984; 33: 609–613
   PubMed Web of Science ®Google Scholar
• Reed D. J. 2-Chloroethylnitrosoureas. Metabolism and Actions of Anti-cancer Drugs, G. Powis, R. A. Prough. Taylor & Francis, London 1987; 1–28
   Google Scholar
• Reed D. J., May H. E. Alkylation and carbamoylation intermediates from the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU). Life Sciences 1975; 16: 1263–1270
   PubMed Web of Science ®Google Scholar
• Reed D. J., May H. E., Boose R. B., Gregory K. M., Beilstan M. A. 2-Chloroethanol formation as evidence for a 2-chloroethyl alkylating intermediate during chemical degradation of 1(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclo-hexyl)-1-nitrosourea. Cancer Research 1975; 35: 568–576
   Google Scholar
• Schein P. S. Nitrosourea antitumour agents. Advances in Cancer Chemotherapy, H. U. Umezn. University Park Press, Baltimore 1978; 95–106
   Google Scholar
• Schmall B., Cheng C. J., Fujimura S., Gersten N., Grunberger D., Weinstein I. B. Modification of proteins by 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) in vitro. Cancer Research 1973; 33: 1921–1924
   Google Scholar
• Seidegard J., Pero R. W., Miller D. G., Beattie E. J. A glutathione transferase in human leucocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751–753
   PubMed Web of Science ®Google Scholar
• Siemann D. W. Effect of pretreatment with phenobarbital and SKF 525A on the toxicity and antitumour activity of lomustine. Cancer Treatment Reports 1983; 67: 259–265
   Google Scholar
• Smith M. T., Evans C. G., Doane-Setzer P., Castro V. M., Tahir M. K., Mannervik B. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumour cells. Cancer Research 1989; 49: 2621–2625
   PubMed Web of Science ®Google Scholar
• Sudhaker S., Tew K. D., Schein P. S., Woolley P. V., Smulson M. E. Nitrosourea interaction with chromatin and effect on poly(ADP-ribose) polymerase activity at the ribosomal level. Cancer Research 1979; 39: 1411–1417
   Google Scholar
• Suzuki E., Osabe M., Okada M., Ismizaka T., Suzuki T. Urinary metabolites of N-nitrosodibutylamine in rat and identification of N-acetyl-S-butyl-L-cysteine derivatives. The Relevance of N-nitroso-Compounds to Human Cancer: Exposures and Mechanisms, H. Bartseh, I. O'Niell, R. Schulte Hermann. IARC Scientific Publications, LyonFrance 1987; 153–155
   Google Scholar
• Talcott R. E., Levin V. A. Glutathione-dependent denitrosation of BCNU in nitrate release catalysed by mouse liver cytosol in vitro. Drug Metabolism and Disposition 1983; 11: 175–176
   Google Scholar
• Taylor A. R., Richards R. P., Lucas C., Gordon B. H., Campbell D. B. (1989) A species comparison of the biodisposition of fotemustine, a novel nitrosourea. 16th International Congress of Chemotherapy, JerusalemIsrael, June, 11–161989
   Google Scholar
• Tew K. D., Sudhaker S., Schein P. S., Smulson M. E. Binding of chlorozotocin and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to chromatin and nucleosomal fractions of HeLa cells. Cancer Research 1978; 38: 3371–3378
   PubMed Web of Science ®Google Scholar
• Tong W. P., Ludlum D. B. Mechanism of action of the nitrosoureas. 1. Role of fluoroethylcytidine in the reaction of bis-fluoroethylnitrosourea with nucleic acids. Biochemical Pharmacology 1978; 27: 77–81
   Google Scholar
• Tong W. P., Kohn K. W., Ludlum D. B. Modifications of DNA by different haloethylnitrosoureas. Cancer Research 1982; 42: 4460–4464
   PubMed Web of Science ®Google Scholar
• Vermeulen N. P. E. Analysis of mercapturic acids as a tool in biotransformation, biomonitoring and toxicological studies. Trends in Pharmacological Sciences 1989; 10: 177–181
   PubMed Web of Science ®Google Scholar
• Vermeulen N. P. E., de Jong J., van Bergen E. J. C., van Welie R. T. H. N-acetyl-S-(2-hydroxyethyl)-L-cysteine as a potential tool in biological monitoring studies. Archives of Toxicology 1989; 63: 173–184
   PubMed Web of Science ®Google Scholar
• Vermeulen N. P. E., van DE Straat R., Te Koppele J. M., Baldew G. S., Commandeur J. N. M., Haenen G. R.M. M., Koymans L., van Welie R. T. H. (1990) Molecular mechanisms in toxicology and drug design. Trends in Drug Research. Proceedings of the Seventh Noordwijkerhout-Camerino Symposium, The Netherlands, September, 5–81989, V. Claassen. Elsevier, Amsterdam, vol. 13: 253–273
   Google Scholar
• Walker M. D., Hilton J. Nitrosourea pharmacodynamics in relation to the central nervous system. Cancer Treatment Reports 1976; 60: 725–728
   Google Scholar
• Wang A. L., Tew K. D., Byrne P. J., Schein P. S. Biochemical and pharmacologic properties of nitrosoureas. Cancer Treatment Reports 1981; 65: 119–124
   Google Scholar
• Weinkam R. J., Lin H. S. Reactions of 1,3 bis(2-chloroethyl)1-nitrosourea and 1-(2-chloroethyl-3-cyclohexyl)1-nitrosourea in aqucous solution. Journal of Medicinal Chemistry 1979; 22: 1193–1198
   PubMed Web of Science ®Google Scholar
• Weinkam R. J., Lin T. Y., Lin H. S. Protein mediated chemical reactions of chloroethyl nitrosoureas. Chemicobiological Interactions 1980; 31: 167–177
   PubMedGoogle Scholar
• Wheeler G. P., Bowdon B. J., Grimsley J., Lloyd H. H. Interrelationships of some chemical, physicochemical and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. Cancer Research 1974; 34: 194–200
   PubMed Web of Science ®Google Scholar
• Wheeler G. P., Bowdon B. J., Struck R. F. Carbamoylation of amino acids, peptides, and proteins by nitrosoureas. Cancer Research 1975; 35: 2974–2984
   Google Scholar
• Wheeler G. P., Johnston T. P., Bowdon B. J., McCaleb G. S., Hill D. L., Montgomery J. A. Comparison of the properties of metabolites of CCNU. Biochemical Pharmacology 1977; 26: 2331–2336
   Google Scholar
• Wolf C. R., Lewis A. D., Carmichael J., Ansell J., Adams D. J., Hickson I. J., Harris A., Balkwill F. R., Griffin D. B., Hayes J. D. Glutathione S-transferase expression in normal and tumor cells resistant to cytotoxic drugs. Glutathione S-transferases and Carcinogenesis, T. J. Mantle, C. B. Pickett, J. D. Haynes. Taylor & Francis, London 1987; 199–212
   Google Scholar